U.S. District Court: In re: Wellbutrin SR antitrust litigation [order and final judgment]
MLex Summary: A Pennsylvania judge has issued an order and final judgment approving a $49 million class settlement between a group of retail pharmacies and British drug giant GlaxoSmithKline. Initially signed in August, the order ends a seven-year battle...To view the full article, register now.
Already a subscriber? Click here to view full article